Top section
Top section
Bot claims funding is ‘cheaper than peers who borrow from independent banks or credit funds’
Innovation and ambition have been hallmarks of mergers and acquisitions activity this year, but there are some signs of weakness in private equity
A slow destruction of misallocated investment is more likely than a sudden stop
More articles
More articles
More articles
-
Palmer Square Capital Management priced a $1bn CLO on Friday, the largest deal of the year arranged by Citi and with no reinvestment period. -
French frozen food producer Picard launched a €1.71bn sustainability-linked dividend deal on Monday, just months after it had to pull a similar deal.
-
ABS lawyers are asking issuers to resist taking advantage of a legal loophole left via a regulatory quirk, where a number of CLO and CMBS deals are technically exempt from switching data over to the securitization repositories approved by the European Securities and Markets Authority (ESMA) on Friday.
-
Personal hygiene company Ontex has launched a bond deal, aiming to replace the bulk of its previously secured capital structure with unsecured debt, and push out its 2022 maturity wall with longer-term funding.
-
Genertec Universal Medical Group, a Hong Kong-listed healthcare services company, has received strong response during syndication for its latest loan.
-
Shui On Land became the first Chinese corporate borrower to sell a sustainability-linked bond (SLB) this week — a move that worked to its advantage.
Sub-sections
shared comment list
